#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Neutropenia Intracranial germ cell tumour Glioblastoma multiforme Chorioretinitis Myeloid leukaemia Depression Plasma cell myeloma Gaucher's disease type III Restless legs syndrome Vulval cancer recurrent Immune-mediated enterocolitis Mitochondrial encephalomyopathy Scedosporium infection Subdural haematoma More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Life with Disease Adrenogenital syndrome – Basic Information Basal cell naevus syndrome – Basic Information Mantle cell lymphoma – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Hypereosinophilic syndrome Anaplastic thyroid cancer – Treatment Mantle cell lymphoma Myxofibrosarcoma Proteus syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ribonucleic Acid Letrozole Dacomitinib Peginterferon Beta-1A Bi 764524 ANTIMETABOLITES Posaconazole Acasunlimab Dolutegravir Sodium Urea Brimonidine ZINC TUVATEXIB Vorinostat Bi 1819479 L-Histidine Hydrochloride Tenofovir Disoproxil Fumarate Zipalertinib Interleukin-1 SOFOSBUVIR More therapies…

    Learn about Your Condition

    Thrombosis prophylaxis Eosinophilic gastritis Hepatic angiosarcoma Relapsing multiple sclerosis Myocarditis Breast conserving surgery Mucopolysaccharidosis Anxiety disorder Knee arthroplasty Colon cancer stage III Tendon disorder Erectile dysfunction Nasal sinus cancer Haemorrhage intracranial Diffuse large B-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness and Safety of Exa-cel for Adolescents and Adults with Severe Sickle Cell Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Exagamglogene Autotemcel
    • Plerixafor
    • Busulfan
    France Italy

  • Study on Moxifloxacin for Treating Uncomplicated Acute Appendicitis in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Moxifloxacin
    Finland

  • Study of ABTL0812 with Irinotecan and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Sodium 2-Hydroxylinoleate
    Spain

  • Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    • D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
    Czechia France Germany Italy The Netherlands Poland +1

  • Study on Cefiderocol for Treating Gram-negative Bacterial Infections in Hospitalized Infants Under 3 Months

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Cefiderocol
    Bulgaria Greece Spain

  • Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Calcium Lactate Gluconate
    • Denosumab
    • Ascorbic Acid
    Bulgaria Estonia Hungary Latvia Poland Slovakia
Previous Page
1 … 882 883 884 885 886 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!